Periodic Reporting for period 1 - ReSpire (Respirable Advanced Therapeutics for Cystic Fibrosis & other Lung Diseases)

OmniSpirant is an Irish company with the vision of providing its unique Cystic Fibrosis (CF) inhaled exosome gene therapy solution to the European and global healthcare sector to combat the respiratory dysfunction caused by CF, a genetic disorder (caused by mutations in the...